Sodium norcantharidate for injection
Function and Efficacy
Some patients may experience gastrointestinal reactions, heart, liver, and kidney damage due to drug overdose. The dosage may be reduced or symptomatic treatment may be given as appropriate.
Ingredients
Main ingredients: The main active ingredient is sodium norcantharidin.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| SodiuM DeMethylcantharidateIngredients |
Some patients may experience gastrointestinal reactions, heart, liver, and kidney damage due to drug overdose. The dosage may be reduced or symptomatic treatment may be given as appropriate. More |
13114-29-9 | 0 |
Indication
It is used for liver cancer, esophageal cancer, stomach and cardia cancer, lung cancer, and leukopenia. It can also be used as a preoperative drug for cancer surgery or in combined chemotherapy.
Usage and Dosage
1. Intravenous injection. Take this product, dissolve and dilute it with an appropriate amount of 5% glucose injection, and slowly push it intravenously. 10~30mg at a time or follow the doctor's advice. For intravenous drip, dissolve it with an appropriate amount of 5% glucose injection, add it to 250~500ml of 5% glucose injection and slowly drip it. 2. Hepatic artery catheterization. Take this product and dissolve it with an appropriate amount of sterile injection water for use. 10~30mg at a time, twice a day. One month is a course of treatment, and it usually lasts for 2~3 courses. 3. Intratumoral injection. Take this product and dissolve it with an appropriate amount of sterile injection water for use. 10~30mg at a time, once a week, 4 times as a course of treatment, and it can last for 4 courses.
Adverse Reactions
If the single injection volume exceeds 30 mg, some patients may experience gastrointestinal symptoms such as nausea and vomiting. The dose can be reduced or symptomatic treatment can be given.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
If the single injection volume exceeds 30 mg, some patients may experience gastrointestinal symptoms such as nausea and vomiting. The dose can be reduced or symptomatic treatment can be given.
Storage
Keep tightly closed.
Packaging Specification
10mg
Manufacturer
Wuxi Taxus Pharmaceutical Co., Ltd.
-
Founded in:
2004-05-31 -
Address:
No. 111, Qinxin Road, Donggang Town, Xishan District, Wuxi City -
Tax NO.:
9132020576243151XT -
Registered Funds:
190.31 million yuan -
Website:
-
Email: